FDA Warns 30 Telehealth Firms Over Compounded GLP-1 Medications

(MedPage Today) — Thirty warning letters were issued to telehealth companies for false and misleading claims about compounded GLP-1 receptor agonist products, the FDA announced on Tuesday.
The letters primarily targeted claims implying “sameness…